Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.35

-0.07 (0.11%)

as of Sep 4, 2026, 4:35:36 pm Market Open.

1632 watching

Investor Insights

Sep 4, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has demonstrated solid performance, particularly in its Asian markets and wealth management divisions, although recent government tax regulations in China pose challenges. Experts generally view MFC as a reliable investment with a decent dividend yield, but caution is advised due to signs of overvaluation in the Canadian financial sector. Comparatively, it is considered attractive relative to banks such as TD, although some analysts express concerns about recent earnings drops and recommend waiting for market pullbacks to buy in. The consensus highlights MFC's solid fundamentals despite a slightly overbought situation, showcasing both short-term challenges and long-term growth potential.

Consensus

Neutral

Valuation

Overvalued

Similar

SLF

BUY

There will be some tax loss selling, which will put pressure on the stock. Disclosed last quarter that not only does it have equity risk because of lack of hedging, but also have US treasury interest rate risk if rates go down. A Buy at these prices.

DON'T BUY

Hasn't owned for several years. Doesn't know if it is worth the risk at this price. Not worth chasing. Prefers Great West (GWO-T), which has a 5% yield.

SELL

Nobody knows where this company is going to go from here. Pure speculation.

BUY ON WEAKNESS

Difficult story. Would probably buy if it got to $10 again. Missed their capital ratios and investors feel they are very much tied to the equity market. Very hard for insurance companies to operate in this low interest-rate environment.

SELL

Both MFC and SLF have exposure to an annuity product that was sold during the bull market. People are fixated on the hedging on this. He would not be standing there to catch these names. There are insurance names that are not in these products. Move into another insurance name.

HOLD

Is a longer-term play. No dividend increases for next couple of years. Volatile. Might come down a bit more. Too cheap to bail out.

COMMENT

7.768% bond due 4/8/19? Risk currently is dilution. Doesn't see any default risk. Once company issues equity or reduces dividend there should be an improvement in these bonds. Fairly priced right now. Prefers buying lower dollar bonds.

TOP PICK

If you believe this market is bottoming and will work higher, this is like a warrant on the market. Oversold. Historically at a historical level +30% below its moving average. This is only happened once before.

WATCH

If rates go lower, this company will have a tough time. Wouldn't touch at this time. If it moves up above $12.80 he would be interested.

WAIT

Doesn’t see a takeover. This is a contrarian play and is on his watch list.

COMMENT

Have been through hell in every sense and he thinks it is probably near the low. If you have gains elsewhere and a big loss here, you might want to take the loss. Probably in for another couple of tough quarters. If your timeframe is 18-24 months and your patient, you should do fine.

HOLD

Thinks there is a window of opportunity in the next 24 months as they get their house in order and become less dependent on equity market performance.

BUY

7.768% Medium Term Note due 4/08/19? There is still AA rating on this company. This is a very strong, solid, investment grade rating. He would be very comfortable with this.

TOP PICK

7.405% bond due 31/12/19.

WATCH

All lifecos’ earnings became more volatile when securities had to be marked to market and had to relate to guarantees made on fixed incomes. If markets continue up, he could see a rebound in the September quarter. Before buying he would like to see stability in markets and rising stock prices on a consistent basis.

Showing 1,426 to 1,440 of 2,284 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Dan Rohinton

iA Global Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)